SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-08-002191
Filing Date
2008-02-27
Accepted
2008-02-27 15:38:46
Documents
12
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K y50008e10vk.htm 10-K 1390461
2 EX-3.1: RESTATED CERTIFICATE OF INCORPORATION y50008exv3w1.htm EX-3.1 51703
3 EX-10.18: DISCOVERY AND PRECLINICAL DEVELOPMENT AGREEMNET y50008exv10w18.htm EX-10.18 317380
4 EX-10.19: LICENSE AND COLLABORATION AGREEMENT y50008exv10w19.htm EX-10.19 563113
5 EX:10.20: STOCK PURCHASE AGREEMENT y50008exv10w20.htm EX-10.20 140735
6 EX-10.21: INVESTOR AGREEMENT y50008exv10w21.htm EX-10.21 153637
7 EX-12.1: STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO COMBINED FIXED CHARGE y50008exv12w1.htm EX-12.1 18309
8 EX-23.1: CONSENT OF PRICEWATERHOUSECOOPERS LLP y50008exv23w1.htm EX-23.1 2029
9 EX-31.1: CERTIFICATION y50008exv31w1.htm EX-31.1 8351
10 EX-31.2: CERTIFICATION y50008exv31w2.htm EX-31.2 8690
11 EX-32: CERTIFICATION y50008exv32.htm EX-32 4461
12 GRAPHIC y50008y5000801.gif GRAPHIC 8968
  Complete submission text file 0000950123-08-002191.txt   2672684
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19034 | Film No.: 08646471
SIC: 2834 Pharmaceutical Preparations